Investing
730 Articles
courtesy of Sirius XM RadioShort sellers continue to hold huge positions not only in troubled companies like BlackBerry Ltd. (NASDAQ:…
In a new research report, the pharmaceutical and biotech analysts at RBC highlight their meetings with a group of six…
bfishshadow via Wikimedia CommonsShort sellers continue to hold huge positions not only in troubled companies like BlackBerry and Staples, but…
The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5.…
ThinkstockBy any stretch of normal measurement in earnings season, Gilead Sciences Inc. (NASDAQ: GILD) should have been a rocketing stock…
24/7 Wall St. wanted to evaluate the prospects for several would-be blockbuster drugs. Some of these have approvals already in…
In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are…
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) and Amgen Inc. (NASDAQ: AMGN) have both reported earnings. This is a definite difference in…
ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off…
In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off…
thinkstockApril 11, 2014: Markets opened lower on Friday with the S&P 500 and the Nasdaq Composite breaking into positive territory…
In a new report, RBC has a list of stocks with some of the largest percentage drops and the lowest…
Gilead Sciences may have been largely responsible for the drop in biotech stocks after politicians went after its drug costs,…
Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back…
The recent violent sell-off has unnerved investors and given the bears the floor for the first time in a while.…
Our top personal finance-related articles today. Your wallet will thank you later.